BRNS

#4619
Barinthus Biotherapeutics plc American Depositary Shares
0.59 USD
-1.67%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
0.59
0.59
Intervallo Annuale
0.51
2.92
Variazione giornaliera
-1.67%
Variazione Mensile
-7.81%
Variazione di 6 mesi
-55.97%
Variazione Annuale
-15.71%
Chiusura Precedente
0.60
Apertura
0.59
Bid
Ask
Minimo
0.59
High
0.59
Volume
1
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 24.1 M
  • Employee 14
  • Founded 2016
  • CEO N/A
  • Website www.barinthusbio.com
  • Headquarter United Kingdom
  • FIGI BBG00ZZPCP09
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.43
Rapporto prezzo/fatturato
—

Barinthus Biotherapeutics plc - American Depositary Shares

Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people.

Notizie